Home › Funds › ADAGE CAPITAL PARTNERS GP, L.L.C. › JNJ

ADAGE CAPITAL PARTNERS GP, L.L.C. position in JNJ

JOHNSON & JOHNSON · Health Care

ADAGE CAPITAL PARTNERS GP, L.L.C. reported holding 2,566,595 shares of JNJ (JOHNSON & JOHNSON) in its Q2 2026 13F filing — a position valued at US$651.8M, representing 0.91% of its reported portfolio and ranking #16 among its reported holdings. ADAGE CAPITAL PARTNERS GP, L.L.C. has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.57M sh
Reported value held$651.84M
Portfolio Weight0.91%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADAGE CAPITAL PARTNERS GP, L.L.C.'s JNJ position evolved

ADAGE CAPITAL PARTNERS GP, L.L.C. first disclosed a stake in JNJ in Q3 2023 at 1,376,303 shares (US$214.4M). The position peaked in Q2 2026 at 2,566,595 shares, worth US$651.8M. Across 12 filings, ADAGE CAPITAL PARTNERS GP, L.L.C. increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,566,595 shares valued at US$651.8M — an increase of 103,587 shares quarter over quarter.. Notable position changes include a 90% increase in Q3 2024 (shares fell 11% over the following quarter), a 42% trim in Q4 2024 (shares rose 12% over the following quarter), a 69% increase in Q3 2025 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.38M $214.36M New
Q4 2023 981.13K $153.78M Reduce
Q1 2024 1.00M $158.40M Add
Q2 2024 852.52K $124.60M Reduce
Q3 2024 1.62M $262.40M Add
Q4 2024 934.80K $135.19M Reduce
Q1 2025 1.28M $212.01M Add
Q2 2025 1.34M $204.16M Add
Q3 2025 2.26M $419.73M Add
Q4 2025 2.21M $457.55M Reduce
Q1 2026 2.46M $602.06M Add
Q2 2026 2.57M $651.84M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has ADAGE CAPITAL PARTNERS GP, L.L.C. held JNJ?

ADAGE CAPITAL PARTNERS GP, L.L.C. has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ADAGE CAPITAL PARTNERS GP, L.L.C.'s current position in JNJ?

As of Q2 2026, ADAGE CAPITAL PARTNERS GP, L.L.C. holds 2.57M shares of JNJ (JOHNSON & JOHNSON), valued at $651.84M, representing 0.91% of its reported portfolio and ranking #16.

Has ADAGE CAPITAL PARTNERS GP, L.L.C. been buying or selling JNJ?

In the latest 13F filing (Q2 2026), ADAGE CAPITAL PARTNERS GP, L.L.C. increased its position in JNJ. The position peaked in Q2 2026 at 2.57M shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.